Circulating Tumor Cell Data: Integration with Imaging and Serum Tumor Markers for Metastatic Breast Cancer Patient Management
Management of metastatic breast cancer is critical to maximizing survival with good quality of life. Circulating tumor cell (CTC) levels in the peripheral blood hold promise for enabling improved patient care. We describe a case of a 47-year-old female with infiltrating ductal carcinoma who develope...
Main Authors: | Thomas Marsland, Eric R. Schuur |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2014-03-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/360983 |
Similar Items
-
Integrating Circulating Tumor Cell Data with Imaging and Serum Prostate-Specific Antigen Measurement for Metastatic Prostate Cancer Therapy Management
by: Oscar Goodman, et al.
Published: (2014-03-01) -
Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker
by: Sayyed Farshid Moussavi-Harami, et al.
Published: (2014-05-01) -
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
by: Maxim E. Menyailo, et al.
Published: (2020-03-01) -
Position of Circulating Tumor Cells in the Clinical Routine in Prostate Cancer and Breast Cancer Patients
by: Gerit Theil, et al.
Published: (2020-12-01) -
Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
by: Giulia Brisotto, et al.
Published: (2020-04-01)